AQHA and Adequan Extend Partnership
AQHA Publicity
The American Quarter Horse Association is proud to announce that the 11-year partnership with American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan) will continue through 2022. American Regent Animal Health is an AQHA official animal health care manufacturer and Adequan® is AQHA’s official equine joint therapy provider.
“AQHA members want the best for their horses, whether they are competing in the performance arena, working on a ranch or riding on the trail,” said Patty Tiberg, AQHA chief marketing and business development officer. “Adequan® is dedicated to the well-being of our equine partners so horses can enjoy all aspects of being a part of AQHA.”
Adequan® is passionate about the American Quarter Horse. Whether AQHA members are involved with pleasure horses, racehorses, performance horses or working horses, Adequan® can be an asset to the team.
“Veterinarians have recommended Adequan® for over 30 years, and we’re pleased that legacy has supported American Quarter Horses,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We look forward to helping keep AQHA horses and riders moving through everything from walks around the barn to elite competitions.”
Adequan® is the title sponsor of the Adequan® Level 2 Championships; the AQHA Select World Championship Show, presented by Adequan® (polysulfated glycosaminoglycan); Adequan® Level 2 Year-End High-Point awards; Adequan® Derby Challenge; and also supports other AQHA programs such as the Farnam AQHA World Championship Show, Built Ford Tough AQHYA World Championship Show, AQHA Versatility Ranch Horse World Championship Show, Nutrena AQHA Level 1 Championships, regional AQHA Level 2 classes and Bank of America Racing Challenge.
About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.
PP-AI-US-0683 07/2021
For more information about Adequan® and other AQHA corporate partners, visit www.aqha.com/partners.
AQHA News and information is a service of the American Quarter Horse Association. For more news and information, follow @AQHA on Twitter and visit www.aqha.com/news.
